← Leaderboards
Myron Nv Williams
Clark Atlanta University
$600,590
Attributed
$600,590
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $163.5K · FY2005–07$200K$150K$100K$50K$0
'05
'06
'07
Funding mix
By agency
NIH$600,590 · 3
By mechanism
G12$518,783 · 2
R03$81,807 · 1
Top collaborators
No co-investigators on record.
Most similar at Clark Atlanta University
Same institution · by research overlap
- Myron N Williams$437,557
- Paul McGeady$1,264,154
- Myren N V Williams$328,179
- Zhengxin Wang$914,016
Others in their field
Top investigators on “Funding”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,479,940,681
- Leonard Freedman · Leidos Biomedical Research, Inc.$968,195,877
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Jeffrey P Krischer · University Of South Florida$358,470,093
Research focus
FundingGrowthMalignant Neoplasm Of ProstateConditionInstitutionNumbersAntitumor AntibodyAntigensAfrican AmericanBackBinding (Molecular Function)BiologicalBiological FactorsBiological MarkersAttentionAntibodiesCancer PatientCancer CellCell LineCellsCell SeparationCell SurfaceCell TypeArhgef5 Gene
Grant awards (5)
Enhanced Research Collaboration in Complimentary and Alternative Medicine$81,807
R03 · FY2007 · AT · contact PI
RECOMBINANT ANTIBODIES AGAINST PROSTATE CANCER ANTIGENS$77,978
G12 · FY2007 · RR · contact PI
RECOMBINANT ANTIBODIES AGAINST PROSTATE CANCER ANTIGENS$119,094
G12 · FY2006 · RR · contact PI
RECOMBINANT ANTIBODIES AGAINST PROSTATE CANCER ANTIGENS$163,505
G12 · FY2005 · RR
RECOMBINANT ANTIBODIES AGAINST PROSTATE CANCER ANTIGENS$158,206
G12 · FY2004 · RR